Abstract |
The oncoproteins MDM2 and MDMX negatively regulate the activity and stability of the tumor suppressor protein p53, conferring tumor development and survival. Antagonists targeting the p53-binding domains of MDM2 and MDMX kill tumor cells both in vitro and in vivo by reactivating the p53 pathway, promising a class of antitumor agents for cancer therapy. Aided by native chemical ligation and mirror image phage display, we recently identified a D- peptide inhibitor of the p53-MDM2 interaction termed (D)PMI-alpha (TNWYANLEKLLR) that competes with p53 for MDM2 binding at an affinity of 219 nM. Increased selection stringency resulted in a distinct D- peptide inhibitor termed (D)PMI-gamma (DWWPLAFEALLR) that binds MDM2 at an affinity of 53 nM. Structural studies coupled with mutational analysis verified the mode of action of these D- peptides as MDM2-dependent p53 activators. Despite being resistant to proteolysis, both (D)PMI-alpha and (D)PMI-gamma failed to actively traverse the cell membrane and, when conjugated to a cationic cell-penetrating peptide, were indiscriminately cytotoxic independently of p53 status. When encapsulated in liposomes decorated with an integrin-targeting cyclic-RGD peptide, however, (D)PMI-alpha exerted potent p53-dependent growth inhibitory activity against human glioblastoma in cell cultures and nude mouse xenograft models. Our findings validate D- peptide antagonists of MDM2 as a class of p53 activators for targeted molecular therapy of malignant neoplasms harboring WT p53 and elevated levels of MDM2.
|
Authors | Min Liu, Chong Li, Marzena Pazgier, Changqing Li, Yubin Mao, Yifan Lv, Bing Gu, Gang Wei, Weirong Yuan, Changyou Zhan, Wei-Yue Lu, Wuyuan Lu |
Journal | Proceedings of the National Academy of Sciences of the United States of America
(Proc Natl Acad Sci U S A)
Vol. 107
Issue 32
Pg. 14321-6
(Aug 10 2010)
ISSN: 1091-6490 [Electronic] United States |
PMID | 20660730
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Liposomes
- Oligopeptides
- Peptides
- Tumor Suppressor Protein p53
- arginyl-glycyl-aspartic acid
- MDM2 protein, human
- Proto-Oncogene Proteins c-mdm2
|
Topics |
- Amino Acid Sequence
- Animals
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Drug Delivery Systems
(methods)
- Drug Screening Assays, Antitumor
- Glioblastoma
(drug therapy, pathology)
- Humans
- Liposomes
- Mice
- Mice, Nude
- Oligopeptides
- Peptides
(pharmacology, therapeutic use)
- Protein Binding
(drug effects)
- Proto-Oncogene Proteins c-mdm2
(metabolism)
- Transplantation, Heterologous
- Tumor Suppressor Protein p53
(metabolism)
|